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METHODS
 Male and female CD-1 mice organized into 3 treatment 
groups and 1 control
 Human exposure to DEHP is from 0 to 200 µg/kg/day
 5 lux corresponds to urban sky
 Animals were acclimated for two weeks and oral dosing 
started after acclimation and was conducted daily at ZT0 
(hours after lights-on) for 30 days 
 Locomotor and feeding behavior data taken for 30 days 
 Locomotor data collected from running wheel activity
 Percent diurnal activity: 100 x [(Activity during 
light phase)/(Total activity)]
 Feeding behavior data collected by measuring food 
weight 2 hours before lights on (Dark phase) and 2 
hours before lights off (Light phase)
 Two days of rest were given after the 30 day data 
collection 
 After 2 days of rest, the elevated plus maze was 
conducted to measure anxiety-like behavior
 An additional 2 days of rest were given before collections 
of brain, liver, ovary, testes, white fat 
INTRODUCTION
The circadian system is an organism’s internal biological 
clock, responsible for regulating physical and behavioral 
activities that follow a daily 24-hour cycle such as sleep 
patterns, feeding habits, and hormone release. These 
rhythms are controlled by the suprachiasmatic nucleus, 
housed in the brain’s hypothalamus. 
Circadian disruption occurs due to an interruption in the 
daily cycle. In humans, circadian disruption is caused by 
several factors, including light at night, shift work, and jet-
lag. This creates problems in the synchronization of 
behavioral and physical activities and can lead to long-
term health conditions. Furthermore, di-(2-ethylhexyl) 
phthalate (DEHP) is a ubiquitous chemical that has been 
shown to induce endocrine disruption, which may further 
modify circadian disruption.
This study aims to test the connection between circadian 
and endocrine disruption. We expect to find abnormal 
locomotor activity and feeding behavior changes in both 
the circadian and endocrine disrupted groups. In the 
combined disruption group, we expect to see an additive 
effect of the two models of disruption. 
LOCOMOTOR ACTIVITY RESULTS FEEDING BEHAVIOR RESULTS CONCLUSIONS
• Weight was not significantly affected by any of 
the treatments 
• DEHP-dLAN treatment did not have an 
additive affect on feeding behavior and 
locomotor activity but the treatment did have a 
significant impact on measures in our model
• DEHP-dLAN treatment changed the 
locomotor activity and feeding behavior in 
females
• DEHP-dLAN changed feeding behavior in 
males but locomotor activity was not 
affected
• DEHP treatment impacted both feeding 
behavior and locomotor activity in male and 
female mice
• dLAN treatment modified the locomotor activity 
and feeding behavior in females
• In males, dLAN changed feeding patterns 
but not locomotor activity  
The data show that exposure to endocrine and 
circadian disruptors commonly found in the 
environment do modify behaviors  
FUTURE DIRECTIONS
• Assess the effects of circadian and endocrine 
disruption on anxiety-like behavior using elevated plus 
maze data
• Analyze vaginal lavage slides to determine any effects 
on estrous cyclicity in females
• Use the brains for gene expression studies in the 
suprachiasmatic nucleus and other brain regions
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Figure 1.  Average activity on running wheel for female mice. There was no significant difference seen in the activity in 
any of the treatment groups compared to the control. The error bars are SEM. n=8 for all treatments. 
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Figure 2.  Average percent diurnal activity in female mice. After 15 days of treatment, DEHP and dLAN groups showed 
increased diurnal activity. After 30 days of treatment, DEHP, DEHP-dLAN, and dLAN groups showed increased 
average diurnal activity. ^p<0.10, *p<0.05, **p<0.001. The error bars are SEM. n=8 for all treatments. 
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Figure 3.  Average total activity across the 30th day of treatment in female mice. Zeitgeber time (ZT) is the number of 
hours after lights were turned on. Mice in all three treatment groups showed increased activity at ZT0 and decreased 
activity in the dark phase (post ZT12). DEHP mice increased activity in the dark phase at ZT19. n=8 for all groups. 
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Figure 4. Average activity on running wheel for male mice. DEHP treated mice had significantly lowered activity after 
30 days of treatment. *p<0.05. The error bars are SEM. n=8 for all treatments. 
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Figure 5.  Average percent diurnal activity in male mice. There was no significant effect of any treatment on diurnal 
activity in males. The error bars are SEM. n=8 for all treatments. 
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Figure 6.  Average total activity across the 30th day of treatment in male mice. Zeitgeber time (ZT) is the number of 
hours after lights were turned on. The mice in dLAN and DEHP-dLAN groups showed increased activity in the dark 
phase. n= 8 for all treatment groups. 
Figure 7. Average percent weight gained in female mice. There was no significant difference in any treatment groups 
on weight gain. The error bars are SEM. n=8 for all treatments. 
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Figure 8. Average food consumption in female mice. DEHP treated mice had significantly higher food consumption at 
and after 10 and 30 days of treatment. *p<0.05, **p<0.01 The error bars are SEM. n=8 for all treatments. 
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Figure 9. Average food consumed in the light and dark phases in female mice. At day 10 during the light phase, dLAN
and DEHP-dLAN treated mice had reduced food consumption. At day 30, DEHP and DEHP-dLAN treatments had 
higher food consumption during the light phase. ^p<0.10, *p<0.05. The error bars are SEM. n=8 for all treatments. 
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Figure 10. Average percent weight gained in male mice. There was no significant difference in weight gain of any 
treatment. The error bars are SEM. n=8 for all treatments. 
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Figure 11. Average food consumption in male mice. DEHP-treated mice had significantly lower food consumption after 
10 and 30 days of treatment. DEHP-dLAN significantly increased total food consumption after 10 days of treatment. 
*p<0.05. The error bars are SEM. n=8 for all treatments. 
Figure 12. Average food consumed in the light and dark phases in male mice. At 10 days, DEHP decreased and dLAN
increased food consumption in the light phase. DEHP-treated mice reduced food intake after 20 days in the dark 
phase. At Day 30, DEHP decreased and dLAN increased food intake in the dark phase. ^p<0.10, *p<0.05. The error 
bars are SEM. n=8 for all treatments. 
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Circadian Disruption Endocrine Disruption
Control No; 12 h light:12 h dark 
cycle
No; corn oil 
DEHP No; 12 h light:12 h dark 
cycle
Yes; 50 µg/kg/day 
DEHP 
dLAN Yes: 5 lux dim light during 
dark phase
No; corn oil
DEHP-
dLAN
Yes; 5 lux dim light during 
dark phase
Yes; 50 µg/kg/day 
DEHP 
